Ambulatory electrocardiographic longitudinal monitoring in a canine model for Duchenne muscular dystrophy identifies decreased very low frequency power as a …
I Barthélémy, JB Su, X Cauchois, F Relaix, B Ghaleh… - Scientific Reports, 2024 - nature.com
Duchenne muscular dystrophy (DMD) patients exhibit a late left ventricular systolic
dysfunction preceded by an occult phase, during which myocardial fibrosis progresses and …
dysfunction preceded by an occult phase, during which myocardial fibrosis progresses and …
Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy
Adeno-associated viruses (AAVs) expressing versions of truncated dystrophin (micro-
dystrophins) are being delivered at high doses to patients with Duchenne muscular …
dystrophins) are being delivered at high doses to patients with Duchenne muscular …
Ambulatory electrocardiographic longitudinal monitoring in dystrophin-deficient dogs identifies decreased Very Low Frequency power as a hallmark of impaired Heart …
I Barthélémy, JB Su, X Cauchois, F Relaix, B Ghaleh… - bioRxiv, 2023 - biorxiv.org
Background Duchenne muscular dystrophy (DMD) patients exhibit a late left ventricular
systolic dysfunction preceded by an occult phase, during which myocardial fibrosis …
systolic dysfunction preceded by an occult phase, during which myocardial fibrosis …
Mitochondria in Duchenne Muscular Dystrophy-induced Cardiomyopathy: A Prospective Therapeutic Target to Improve Treatment Response
S Gandhi, HL Sweeney, CC Hart, R Han, CGR Perry - 2024 - preprints.org
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by
mutations to the dystrophin gene-resulting in deficiency of dystrophin protein, loss of …
mutations to the dystrophin gene-resulting in deficiency of dystrophin protein, loss of …